5,6-dihydro-5-azacytidine has been researched along with Neoplasms, Pleural in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antman, KH; Cirrincione, C; Citron, ML; Corson, JM; Green, MR; Harmon, DC; Herndon, JE; Suzuki, Y; Yogelzang, NJ | 1 |
| Aisner, J; Carey, R; Corson, JM; Green, MR; Harmon, DC; Herndon, JE; Samuels, BL; Suzuki, Y; Vogelzang, NJ | 1 |
| Dhingra, HM; Hong, WK; Murphy, WK; Raber, MN; Winn, RJ | 1 |
3 trial(s) available for 5,6-dihydro-5-azacytidine and Neoplasms, Pleural
| Article | Year |
|---|---|
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Arrhythmias, Cardiac; Azacitidine; Chest Pain; Female; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms | 1997 |
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chest Pain; Cisplatin; Female; Humans; Leukopenia; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Prognosis; Survival Analysis | 1998 |
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Drug Evaluation; Female; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms | 1991 |